BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27051254)

  • 1. The Author's Response: Assessment of Breast Cancer Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use.
    Kim SI; Lim MC; Lee ES
    J Korean Med Sci; 2016 Apr; 31(4):647. PubMed ID: 27051254
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor: Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use: Scientific Views.
    Das S; Mahakkanukrauh P
    J Korean Med Sci; 2016 Apr; 31(4):646. PubMed ID: 27051253
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of Breast Cancer Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use.
    Kim SI; Lee Y; Son Y; Jun SY; Yun S; Bae HS; Lim MC; Jung SY; Joo J; Lee ES
    J Korean Med Sci; 2015 Nov; 30(11):1604-10. PubMed ID: 26539004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial carcinoma in a tamoxifen-treated breast cancer patient.
    Jose R; Kekre AN; George SS; Seshadri L
    Aust N Z J Obstet Gynaecol; 1995 May; 35(2):201. PubMed ID: 7677690
    [No Abstract]   [Full Text] [Related]  

  • 5. [Postmenopausal hemorrhage and endometrial cancer in tamoxifen therapy].
    Krause A; Gerber B
    Zentralbl Gynakol; 1994; 116(1):44-7. PubMed ID: 8147180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
    McCaul KA
    Obstet Gynecol; 2005 Jan; 105(1):217-8; author reply 218-9. PubMed ID: 15625169
    [No Abstract]   [Full Text] [Related]  

  • 7. Tamoxifen and risk of endometrial cancer.
    Marsh F; Mayfield M
    Lancet; 2001 Jan; 357(9249):68. PubMed ID: 11197382
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamoxifen and risk of endometrial cancer.
    Kairies P
    Lancet; 2001 Jan; 357(9249):68. PubMed ID: 11197381
    [No Abstract]   [Full Text] [Related]  

  • 9. Tamoxifen and risk of endometrial cancer.
    Lasset C; Bonadona V; Mignotte H; Brémond A
    Lancet; 2001 Jan; 357(9249):66-7. PubMed ID: 11197379
    [No Abstract]   [Full Text] [Related]  

  • 10. Tamoxifen and risk of endometrial cancer.
    Atkins CD
    Lancet; 2001 Jan; 357(9249):65; author reply 67. PubMed ID: 11197378
    [No Abstract]   [Full Text] [Related]  

  • 11. Tamoxifen and risk of endometrial cancer.
    Tempfer C; Kubista E
    Lancet; 2001 Jan; 357(9249):65; author reply 67. PubMed ID: 11197377
    [No Abstract]   [Full Text] [Related]  

  • 12. Tamoxifen and risk of endometrial cancer.
    Narod SA; Pal T; Graham T; Mitchell M; Fyles A
    Lancet; 2001 Jan; 357(9249):65-6; author reply 67. PubMed ID: 11197376
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of tamoxifen therapy on endometrium in breast cancer patients].
    Jiang SS; Tao RF
    Zhonghua Fu Chan Ke Za Zhi; 1995 Jan; 30(1):53-5. PubMed ID: 7750409
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for endometrial cancer in the patient receiving tamoxifen for breast cancer.
    Barakat RR
    J Clin Oncol; 1999 Jul; 17(7):1967-8. PubMed ID: 10561245
    [No Abstract]   [Full Text] [Related]  

  • 15. Tamoxifen and endometrial cancer.
    Segna RA; Dottino PR; Deligdisch L; Cohen CJ
    Mt Sinai J Med; 1992 Oct; 59(5):416-8. PubMed ID: 1435840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gynecologic tumors in tamoxifen-treated women with breast cancer.
    Cohen I; Altaras MM; Beyth Y
    Obstet Gynecol; 1994 Jan; 83(1):158-9. PubMed ID: 8272299
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
    Gal D; Weiselberg L; Runowicz CD
    J Natl Cancer Inst; 1994 Aug; 86(16):1252-3; author reply 1255. PubMed ID: 8040896
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of induction of endometrial hyperplasia with tamoxifen.
    Touraine P; Driguez P; Cartier I; Yaneva H; Kuttenn F; Mauvais-Jarvis P
    Lancet; 1995 Jan; 345(8944):254-5. PubMed ID: 7823732
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of GPR30 in endometrial pathology after tamoxifen for breast cancer.
    Ignatov T; Eggemann H; Semczuk A; Smith B; Bischoff J; Roessner A; Costa SD; Kalinski T; Ignatov A
    Am J Obstet Gynecol; 2010 Dec; 203(6):595.e9-16. PubMed ID: 20965484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.